- Home
- YHGJ vs PRPH Comparison
YHGJ vs PRPH Comparison
Compare YHGJ & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YHGJ
- PRPH
- Stock Information
- Founded
- YHGJ 1975
- PRPH 1989
- Country
- YHGJ United States
- PRPH United States
- Employees
- YHGJ N/A
- PRPH N/A
- Industry
- YHGJ Specialty Chemicals
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- YHGJ Industrials
- PRPH Health Care
- Exchange
- YHGJ Nasdaq
- PRPH Nasdaq
- Market Cap
- YHGJ 17.1M
- PRPH 14.5M
- IPO Year
- YHGJ 1997
- PRPH 1997
- Fundamental
- Price
- YHGJ $0.57
- PRPH $0.35
- Analyst Decision
- YHGJ
- PRPH
- Analyst Count
- YHGJ 0
- PRPH 0
- Target Price
- YHGJ N/A
- PRPH N/A
- AVG Volume (30 Days)
- YHGJ 161.6K
- PRPH 15.5M
- Earning Date
- YHGJ 08-14-2025
- PRPH 08-13-2025
- Dividend Yield
- YHGJ N/A
- PRPH N/A
- EPS Growth
- YHGJ N/A
- PRPH N/A
- EPS
- YHGJ N/A
- PRPH N/A
- Revenue
- YHGJ $18,964,000.00
- PRPH $5,588,000.00
- Revenue This Year
- YHGJ N/A
- PRPH $221.82
- Revenue Next Year
- YHGJ N/A
- PRPH N/A
- P/E Ratio
- YHGJ N/A
- PRPH N/A
- Revenue Growth
- YHGJ 5.70
- PRPH N/A
- 52 Week Low
- YHGJ $0.43
- PRPH $0.22
- 52 Week High
- YHGJ $1.27
- PRPH $3.00
- Technical
- Relative Strength Index (RSI)
- YHGJ 44.10
- PRPH 52.15
- Support Level
- YHGJ $0.52
- PRPH $0.28
- Resistance Level
- YHGJ $0.62
- PRPH $0.35
- Average True Range (ATR)
- YHGJ 0.06
- PRPH 0.02
- MACD
- YHGJ 0.01
- PRPH 0.00
- Stochastic Oscillator
- YHGJ 29.18
- PRPH 64.14
About YHGJ Yunhong Green CTI Ltd.
Yunhong Green CTI Ltd manufactures and marketers of foil balloons and produces laminated and printed films for commercial uses. The company also distributes balloon-inspired and other gift items, and continues development of compostable material solutions, and markets its products throughout the United States and in several other countries.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.